165 related articles for article (PubMed ID: 1774441)
1. Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH.
Gam AN; Jensen GF; Hasselstrøm K; Olsen M; Nielsen KS
J Endocrinol Invest; 1991 Jun; 14(6):451-5. PubMed ID: 1774441
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
[TBL] [Abstract][Full Text] [Related]
4. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
5. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
Marcocci C; Golia F; Vignali E; Pinchera A
J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone treatment aiming at reduced, but not suppressed, serum thyroid-stimulating hormone levels in nontoxic goitre: effects on bone metabolism amongst premenopausal women.
Knudsen N; Faber J; Sierbaek-Nielsen A; Vadstrup S; Sørensen HA; Hegedüs L
J Intern Med; 1998 Feb; 243(2):149-54. PubMed ID: 9566644
[TBL] [Abstract][Full Text] [Related]
7. Serum sex hormone-binding globulin and osteocalcin in systemic nonthyroidal illness associated with low thyroid hormone concentrations.
Seppel T; Becker A; Lippert F; Schlaghecke R
J Clin Endocrinol Metab; 1996 Apr; 81(4):1663-5. PubMed ID: 8636386
[TBL] [Abstract][Full Text] [Related]
8. Bone mass, bone turnover, calcium homeostasis, and body composition in surgically and radioiodine-treated former hyperthyroid patients.
Langdahl BL; Loft AG; Eriksen EF; Mosekilde L; Charles P
Thyroid; 1996 Jun; 6(3):169-75. PubMed ID: 8837322
[TBL] [Abstract][Full Text] [Related]
9. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C
Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
[TBL] [Abstract][Full Text] [Related]
10. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.
Marcocci C; Golia F; Bruno-Bossio G; Vignali E; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):818-23. PubMed ID: 8157704
[TBL] [Abstract][Full Text] [Related]
11. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
Akalin A; Colak O; Alatas O; Efe B
Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
[TBL] [Abstract][Full Text] [Related]
12. Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy.
Langdahl BL; Loft AG; Eriksen EF; Mosekilde L; Charles P
Eur J Endocrinol; 1996 Jun; 134(6):702-9. PubMed ID: 8766939
[TBL] [Abstract][Full Text] [Related]
13. Serum osteocalcin levels in hyperthyroidism before and after antithyroid therapy.
Barsal G; Taneli F; Atay A; Hekimsoy Z; Erciyas F
Tohoku J Exp Med; 2004 Jul; 203(3):183-8. PubMed ID: 15240927
[TBL] [Abstract][Full Text] [Related]
14. Early changes in parameters of bone and mineral metabolism during therapy for hyper- and hypothyroidism.
Sabuncu T; Aksoy N; Arikan E; Ugur B; Tasan E; Hatemi H
Endocr Res; 2001; 27(1-2):203-13. PubMed ID: 11428712
[TBL] [Abstract][Full Text] [Related]
15. Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism.
Ross DS; Ardisson LJ; Nussbaum SR; Meskell MJ
J Clin Endocrinol Metab; 1991 Feb; 72(2):507-9. PubMed ID: 1991818
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial.
Benvenga S; Ruggeri RM; Russo A; Lapa D; Campenni A; Trimarchi F
J Clin Endocrinol Metab; 2001 Aug; 86(8):3579-94. PubMed ID: 11502782
[TBL] [Abstract][Full Text] [Related]
17. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
Pantazi H; Papapetrou PD
J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
[TBL] [Abstract][Full Text] [Related]
18. Improved sensitivity of serum thyrotropin measurements. Studies on serum sex hormone-binding globulin in patients with reduced serum thyrotropin.
Faber J; Gam A; Siersbaek-Nielsen K
Acta Endocrinol (Copenh); 1990 Nov; 123(5):535-40. PubMed ID: 2256433
[TBL] [Abstract][Full Text] [Related]
19. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
Peterson ME; Melián C; Nichols R
J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
[TBL] [Abstract][Full Text] [Related]
20. Effect of D-thyroxine on serum sex hormone binding globulin (SHBG), testosterone, and pituitary-thyroid function in euthyroid subjects.
Yosha S; Fay M; Longcope C; Braverman LE
J Endocrinol Invest; 1984 Oct; 7(5):489-94. PubMed ID: 6542576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
